Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Taxotere in High-Risk Prostate Cancer
NCT00069888Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2001
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by Sanofi. Started Nov 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00069888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069888.